Ann: COVID-19 Investor Presentation, page-12

Certainly sounds like numerous interested partners for both funding through trials and commercialisation. Absolutely brilliant presentation. Well thought out and plenty of great information. Was especially good having Professor Bennet there to explain more of the science and improve understanding around the unique position ResApp is in. Looking forward to this progressing. If there is a CR or any other form of funding then I'm all for it. There's a +$100b covid diagnostic market (by 2027) out there to get a jump start on. Remember... No one else has precovid cough signature data like we do. The breatheasy data is now worth it's weight in gold. Forget the fact we failed to gain FDA back then. The fact that we did those trails now puts us in a position that no other company on the planet can ever replicate... What's that worth to you!!!